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Introduction
Voltage-dependent calcium channels (VDCCs) play a fundamental role in the coupling of membrane depolarization to many cellular processes by regulating cytoplasmic Ca 2+ concentration in excitable cells. They are heteromultimers consisting of a pore-forming a 1 subunit assembled with auxiliary b, a2d and possibly g subunits. These subunits can be encoded by several different genes with alternative splice variants and are expressed in a tissue-speci®c manner. Much work has concentrated on the characterization of functional properties of the a 1 , b and a2d subunits (Birnbaumer et al., 1998; Dolphin, 1998; Jones, 1998; Perez-Reyes, 1998; Catterall, 2000) . However, research concerning the role of the g subunit has not been as extensive.
Until recent years, only a single gene, exclusively expressed in skeletal muscle, was believed to encode a VDCC g subunit (Jay et al., 1990; Powers et al., 1993) . Recordings of Ca 2+ currents from dihydropyridine receptors (DHPRs) of skeletal myotubes from mice lacking this g 1 subunit suggest that its role is to limit calcium entry through these channels, increase the rate at which the channels inactivate and hyperpolarize the half-maximal potential for the voltage dependence of steady-state inactivation (Freise et al., 2000; Ahern et al., 2001 ). Subsequently, a second putative VDCC g subunit, g 2 , was identi®ed based on its structural similarity to g 1 , despite having only weak protein sequence identity (25%) (Letts et al., 1998) . Mutations in the g 2 gene, cacng2, were found to underlie the absence epilepsy phenotype of the allelic stargazer (stg) and waggler (wag) mutant mice. Subsequent studies have identi®ed six further putative g subunits (g 3 ±g 8 ), not all of which have been cloned and expressed (Black and Lennon, 1999; Burgess et al., 1999 Burgess et al., , 2001 Klugbauer et al., 2000) .
The g 2 , g 3 and g 4 subunits form a subfamily exclusively localized to the central nervous system (CNS) (Letts et al., 1998; Klugbauer et al., 2000) whose interaction with VDCCs has been investigated in several studies (Letts et al., 1998; Klugbauer et al., 2000; Kang et al., 2001; Sharp et al., 2001) . The g 5 and g 7 subunits (Burgess et al., 1999 (Burgess et al., , 2001 ) are predicted to represent another subfamily of stargazin-related proteins, with extremely low sequence identity to g 1 and~25% identity to g 2 . These subunits, like other members of the putative g subunit superfamily, are proteins predicted to have four transmembrane segments with intracellular N-and C-termini, and were reported to be encoded by a gene assembled from four exons (Burgess et al., 2001) . However, assembly of the full-length g 5 and g 7 cDNAs has not been described and there are no functional data for either of these g subunits.
In the present study, we report the identi®cation, cloning and functional characterization of a novel protein we have named the g 7 subunit. The ®rst four exons of the gene encoding this protein are identical to those encoding the predicted g 7 subunit gene previously described by Burgess et al. (2001) , but the transcription and translation of a ®nal ®fth exon results in the g 7 described in the present study having a very different and much longer C-terminus. Our results show that the co-expression of the g 7 subunit almost abolishes the functional expression and markedly suppresses the level of Ca V 2.2 subunit protein. We also report the identi®cation of the g 5 subunit which, like g 7 , is predicted to be encoded by a ®ve-exon gene.
The novel product of a ®ve-exon stargazin-related gene abolishes Ca V 2.2 calcium channel expression The EMBO Journal Vol. 21 No. 7 pp. 1514±1523, 2002 Results Cloning of the g 5 and g 7 genes The full-length mouse stargazin sequence (Letts et al., 1998) was used as a query sequence to search the DNA databases. A short 487 bp sequence was assembled from three expressed sequence tags (ESTs) and was found to contain an open reading frame (ORF) with 26% identity to stargazin, although it contained no in-frame start or stop codons.
A 487 bp fragment corresponding to this in silico sequence was ampli®ed from human whole brain cDNA, and sequence analysis con®rmed the computer predictions. Primers speci®c for each end of this fragment were used to amplify the missing parts of the ORF using 5¢ and 3¢ RACE. A 330 bp fragment containing the missing 5¢ sequence and start ATG codon, and a 400 bp band containing the missing 3¢ sequence and stop codon were obtained. These three DNA fragments were then used to assemble the full-length 828 bp stargazin-like ORF in a single`splice-overlap' PCR.
When this full-length sequence was used to search the human high-throughput genomic sequences (HTGS) using the BLASTn algorithm, a bacterial arti®cial chromosome (BAC), clone AC008440, derived from human chromosome 19 was identi®ed. Analysis of this BAC using the gene prediction program Genscan (Burge and Karlin, 1997) predicts that the 828 bp ORF is assembled from ®ve exons and encodes a 275 amino acid protein.
When compared with all of the previously published g subunits, this 828 bp cDNA clone exhibited 100% identity to the previously predicted human g 7 subunit over the ®rst four exons (Burgess et al., 2001) . However, the sequence of the cDNA clone described here diverges from the g 7 sequence (Burgess et al., 2001) , due to the presence of the ®fth exon ( Figure 1A and B). It would therefore appear that CACNG7 is in fact a ®ve-exon gene that encodes the g 7 subunit, and the previously predicted four-exon g 7 sequence results from read-through into intron four ( Figure 1B) .
BLAST searches of mouse HTGS identi®ed cacng7, the mouse orthologue of the g 7 gene within BAC AC079557, which, like its human counterpart, contained ®ve exons. Con®rmation that the mouse g 7 mRNA is expressed was obtained by amplifying the complete cDNA in a single RT±PCR from mouse cerebellar total RNA. The mouse orthologue possesses 70% identity to the human g 7 at the nucleic acid level and, remarkably, 100% identity at the protein level.
BLASTn searches and Genscan analysis of human chromosome 17 BAC AC005988 identi®ed another related gene encoding a 275 amino acid protein. This gene also possessed ®ve exons and predicted a protein with 70.5% amino acid identity compared with the human g 7 and 27% identity compared with human g 2 . It exhibited 100% identity to the previously described human g 5 subunit (Burgess et al., 1999) over its ®rst 190 amino acids but, like the g 7 subunit, the additional ®fth exon encodes an alternative C-terminus. Unlike the previously predicted four-exon g 5 and g 7 , the C-termini of the ®ve-exon g 5 and g 7 share considerable identity (80%, Figure 1A ). We therefore named this subunit g 5 (gene CACNG5) and subsequently identi®ed the mouse orthologue on mouse chromosome 16 BAC AC079424. The mouse orthologue (cacng5) exhibited 89.5% identity at the nucleotide level and 97% identity at the protein level to the human sequence.
Hydropathy plots predict that, like all the stargazinrelated proteins, g 7 and g 5 have four transmembranespanning a-helices with predicted intracellular N-and C-termini ( Figure 1C ). The ®nal transmembrane-spanning a-helices of g 7 and g 5 are predicted to be six and eight amino acids longer, respectively, than their equivalents in the previously predicted four-exon g 7 or g 5 , and the full-length g 7 has a much more substantial cytosolic C-terminus than in the predicted four-exon g 7 , in which only four intracellular amino acids are predicted after the ®nal transmembrane segment.
The sequences have been deposited in the DDBJ/ EMBL/GenBank database with the following accession Nos: human g 7 (AF458897), human g 5 (AF458898), mouse g 7 (AF458899) and mouse g 5 (AF458900).
Tissue distribution
The tissue distribution of the novel g 7 mRNA was analysed by northern blot. Figure 2 shows a human multiple tissue northern blot ( Figure 2A ) and two brain region blots ( Figure 2B and C) hybridized with a probe corresponding to nucleotides 576±763 of the g 7 ORF. This region was chosen because it contains the least identity when compared with other g-subunits (53% to human g 2 ), and is unique to g 7 . Thus, this probe will not detect the predicted four-exon g 7 , should this be expressed. This g 7 -speci®c probe reveals two transcripts of~2.4 and 3.0 kb, both of which are expressed only in brain. Both of these transcripts are expressed in all brain regions probed, although the shorter transcript is expressed at greater levels in several areas including cerebellum, amygdala, hippocampus and thalamus. These blots were stripped and re-probed using the same probe as that designed to detect the four-exon g 7 (Burgess et al., 2001) . This probe, corresponding to nucleotides 80±482 of the g 7 ORF, would detect both the predicted four-exon g 7 and full-length g 7 transcripts. No additional transcripts were seen in any of the blots with this probe. Indeed, precisely the same expression pro®le was seen as with the full-length g 7 -speci®c probe, including the same differential expression of the short and long transcripts seen in cerebellum, amygdala, hippocampus and thalamus (data not shown).
In¯uence of the g 7 subunit on heterologous expression of VDCCs and K V 3.1b Having investigated the tissue distribution of the g 7 subunit in human brain, we next examined the effect of expression of this protein on Ba 2+ currents recorded from neuronal VDCCs expressed in COS-7 cells. For comparison with immunocytochemistry data (see below), we transfected an N-terminal green¯uorescent protein-tagged Ca V 2.2 construct (GFP±Ca V 2.2), previously shown to have no signi®cant differences in its biophysical properties compared with the non-tagged channel (Raghib et al., 2001) . These experiments revealed an almost total abolition of whole-cell GFP±Ca V 2.2 Ba 2+ current (I Ba ) in cells cotransfected with g 7 ( Figure 3A , upper trace). In 1 mM Ba 2+ , mean current density of cells expressing GFP±Ca V 2.2/b 1b / a2d 2 was ±13.5 T 4.3 pA/pF at 0 mV (n = 20) ( Figure 3B) but, even when extracellular [Ba 2+ ] was increased to 10 mM, currents from GFP±Ca V 2.2/b 1b /a2d 2 /g 7 -transfected COS-7 cells remained extremely small (±0.23 T 0.08 pA/pF at 0 mV, n = 20, P <0.01) ( Figure 3A , lower trace, and B). In a recent report, it was stated that inhibition of Ca V 2.2 currents by the g 2 subunit was dependent upon co-expression of an a2d subunit (Kang et al., 2001) . To investigate if the same is true of the much more robust suppressive effect of g 7 , recordings were made from cells in the absence of cotransfected a2d 2 subunit. The histograms in Figure 3B show that the in¯uence of the g 7 subunit on Ca V 2.2/b 1b currents was independent of co-expression of an a2d subunit (Ca V 2.2/b 1b , ±14.9 T 2.7 pA/pF at 0 mV in 1 mM Ba 2+ , n = 16; Ca V 2.2/b 1b /g 7 , ±0.02 T 0.03 pA/pF at 0 mV in 10 mM Ba 2+ ; n = 18, P <0.01). Fig. 1 . Protein sequences, proposed splicing mechanism and hydropathy plots of a family of low homology stargazin-related genes. (A) Alignment of the ®ve-exon g 5 and g 7 subunit sequences with the previously predicted four-exon g 5 and g 7 subunits using the Clustal_W algorithm. Dotted lines indicate consensus N-glycosylation sites and solid triangles beneath residues mark consensus sites for phosphorylation by cAMP-and cGMP-dependent protein kinase, protein kinase C, casein kinase II or tyrosine kinase. The exon±intron boundaries are marked by solid dots above the residue whose codon is interrupted by the adjacent intron. Note that the sequence identity between g 5 and g 7 is 80% conserved throughout the additional ®fth exon, whereas the predicted four-exon g 5 and g 7 subunits differ greatly in sequence identities and length. The two large open triangles designate a pair of cysteine residues that are conserved amongst the putative VDCC g subunits and may be involved in the formation of disul®de bridges. The transmembrane-spanning segments, as predicted by the TMpred program (Hofmann and Stoffel, 1993) , are indicated by solid underlining. The residues highlighted in bold in the C-terminus of g 7 identify the epitope for the anti-g 7 antibody. (B) A schematic diagram of the g 5 and g 7 gene structure. The full-length genes are encoded by ®ve exons interrupted by four introns, I1±I4. If the previously predicted four-exon g 5 and g 7 subunits were expressed, the extent of predicted read-through into intron 4 is displayed above the gene structure. The start codon, terminal amino acids of exon 4, and both normally spliced and intron-retained g 5 or g 7 are shown below the gene structure. (C) Hydropathy plots of the ®ve-exon g 5 and g 7 subunits predicted by the TMpred program (Hofmann and Stoffel, 1993) compared with the previously predicted four-exon g 5 and g 7 . Amino acid position is shown on the x-axis, and positive TMpred values indicate putative membrane-spanning regions. g 7 and g 5 are predicted to have four transmembrane-spanning a-helices with intracellular N-and C-termini.
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To examine whether these effects were peculiar to transfection in mammalian expression systems, we next looked at the effect of g 7 on Ca V 2.2 currents expressed in Xenopus oocytes, where there cannot be any question as to whether all cDNAs are present in each cell. Figure 3C shows recordings made in 5 mM Ba 2+ from Xenopus oocytes expressing Ca V 2.2/b 1b either with or without coexpression of g 7 . The maximum conductance (G max ), determined from the current±voltage (I±V) plots, was dramatically and signi®cantly reduced when the human g 7 subunit was co-expressed compared with oocytes where it was not, with a corresponding 92.6% reduction in peak current amplitude at 0 mV ( Figure 3C and Table I ). The half-maximal value for the voltage dependence of activation (V 50 ) was also shifted 3.4 mV more depolarized upon co-expression of g 7 . An almost identical 94% inhibition of Ca V 2.2/b 1b /a2d 2 currents was observed by g 7 in this system (data not shown). To examine whether the residual current represents the current induced by auxiliary subunits in Xenopus oocytes (Lacerda et al., 1994) , we examined currents from oocytes transfected with only the auxiliary subunit b 1b . However, we observed that these currents were also reduced from ±28.1 T 9.6 nA (n = 10) to ±8.3 T 5.3 nA (n = 9) upon co-expression of g 7 . We next investigated the effects of g 7 on other Ca V a 1 subtypes. The g 7 subunit also signi®cantly reduced the G max of Ca V 2.1/ b 1b and Ca V 1.2/b 1b VDCCs by 48 and 52%, respectively ( Figure 4A and B, Table I ). There were no signi®cant effects of g 7 on their voltage dependence of activation (Table I) . Thus, the effect of g 7 on these channels is not as striking as that seen with Ca V 2.2.
Together with the data generated in COS-7 cells, the near complete abolition of Ca V 2.2 current seen in Xenopus (upper panel) . In the presence of g 7 , extracellular Ba 2+ solution was also increased to 10 mM (lower panel). (B) Histogram of mean current densities measured at +10 mV in 1 mM Ba 2+ for controls and 10 mM Ba 2+ in the presence of g 7 . Co-expression of g 7 abolished currents in both the presence and absence of the a2d 2 subunit. The number of experiments (n) for each condition is given in parentheses above the columns, and data from all cells tested are included (**P <0.01, Student's t-test). (C) Peak I±V relationships and individual representative traces for Ca V 2.2 (solid diamonds, n = 26) and Ca V 2.2 + g 7 (open diamonds, n = 24), expressed in Xenopus oocytes with the b 1b auxiliary subunit were determined by measuring peak Ba 2+ current amplitudes recorded during 100 ms test pulses between ±70 and +40 mV (holding potential ±100 mV; +10 mV increments; [Ba 2+ ] in extracellular medium: 5 mM). Data are expressed as mean T SEM of the number of replicates, n. *P <0.05, **P <0.01 and ***P <0.001 according to an unpaired Student's t-test. The peak I Ba was at +10 mV for Ca V 2.1 and Ca V 1.2 and at 0 mV for Ca V 2.2.
g 7 abolishes Ca V 2.2 calcium channel expression oocytes upon co-expression of the g 7 subunit suggests that it may be affecting the expression of these channels rather than altering their biophysical properties. However, since the effect of g 7 on the Ba 2+ currents through Ca V 2.2 VDCCs expressed in COS-7 cells or Xenopus oocytes was so striking, we investigated the possibility that it downregulates other heterologously expressed ion channels by co-expressing it with the Shaw-like voltage-dependent potassium channel, K V 3.1b. Figure 4C shows representative traces and the peak I±V relationship of K V 3.1b currents expressed in Xenopus oocytes alone and coexpressed with the g 7 subunit, which indicate that the g 7 subunit had no effect on the peak current amplitude of heterologously expressed K V 3.1b channels.
In¯uence of the g 7 subunit on endogenous Ca 2+ currents recorded from cultured sympathetic neurones We investigated the electrophysiological consequence of the acute expression of g 7 upon the endogenous VDCC currents from sympathetic neurones of the rat superior cervical ganglion (SCG). These neurones express 80±90% N-type and 10% L-type current (Plummer et al., 1989; Delmas et al., 1998) and provided a vehicle in which we could determine if the g 7 subunit could exert its in¯uence upon pre-existing Ca 2+ channels. Whole-cell patch-clamp recordings, performed 36±48 h post-isolation and transfection from control sympathetic neurones transfected with the GFP marker , gave a mean I Ba current density at 0 mV of ±13.6 T 2.6 pA/pF (n = 6). However, this was not signi®cantly altered in neurones transfected with GFP and the g 7 subunit (±15.2 T 3.5 pA/pF, n = 6) ( Figure 5A ). Expression of g 7 protein in g 7 -transfected neurones was veri®ed by immunocytochemistry ( Figure 5B ), which also demonstrated the presence of only a very low level of immunoreactivity for endogenous g 7 in neurones transfected with GFP alone ( Figure 5B ). Although the morphology of sympathetic neurones cultured for 36±48 h is quite variable, in a preliminary observation, we also noted an alteration in neurite morphology in sympathetic neurones transfected with g 7 (Figure 5B ), but this will require further detailed examination in a future study. It would therefore appear that the g 7 subunit is unable to acutely in¯uence the properties of pre-existing N-type VDCCs in these neurones, and that g 7 does not co-exist endogenously in SCG neurones with N-type channels.
Immunocytochemical analysis of the effects of the g 7 subunit The subcellular distribution of the expressed g 7 subunit and its effects upon the expression of Ca V 2.2 subunits were determined using immunocytochemistry and confocal laser scanning microscopy. When the g 7 subunit alone was transiently transfected into COS-7 cells ( Figure 6A ), expression of g 7 protein was observed throughout the cytoplasm and not speci®cally associated with the plasma membrane (delineated by Oregon Green±phalloidin). Figure 6B shows the typical¯uores- cence pattern of a cell transiently transfected with GFP±Ca V 2.2/b 1b. Figure 6C shows two cells where the g 7 subunit has also been co-transfected. A striking reduction in the¯uorescence of GFP±Ca V 2.2 was observed upon co-expression of the g 7 subunit, whilst the g 7 levels remained comparable with those in cells transfected with the g 7 subunit alone. Immunocytochemical methods also con®rmed the earlier electrophysiological ®ndings that the g 7 subunit does not adversely affect the expression of the K V 3.1b subunit. Figure 6D displays the expression of a g 7 -myc/his fusion protein expressed alone in a COS-7 cell. The expression pattern of this construct is similar to that of the untagged g 7 ( Figure 6A ). Shown in Figure 6E is the expression of K V 3.1b when transfected alone. The distribution and the expression level of K V 3.1b were unaltered by the coexpression of the g 7 -myc/his fusion protein ( Figure 6F ).
In transient transfections, co-transfected subunits are not always co-expressed in every cell. We therefore sought to quantify the extent of the reduction in observed GFP±Ca V 2.2¯uorescence caused by g 7 subunit coexpression. This was measured by counting the number of GFP-positive cells in both the GFP±Ca V 2.2/b 1b -and GFP±Ca V 2.2/b 1b /g 7 -transfected cultures. The mean percentage of the total cells per 16 mm 2 ®eld of view with GFP±Ca V 2.2¯uorescence, which entirely co-localizes with b 1b expression, was reduced from 16.4 T 3.4% in GFP±Ca V 2.2/b 1b -transfected cells to 3.3 T 0.7% in cells additionally transfected with the g 7 subunit ( Figure 7A) . The same histogram also shows that almost all cells that exhibited GFP±Ca V 2.2¯uorescence in the Ca V 2.2/b 1b /g 7 transfections were also labelled for g 7 (3.0 T 0.7%) , implying that there is some residual GFP±Ca V 2.2¯uores-cence in some cells expressing the g 7 subunit. The Fig. 6 . Co-expression of g 7 with GFP±Ca V 2.2 almost abolishes GFP¯uorescence in COS-7 cells. Cells were transfected with (A) the g 7 subunit alone, (B) GFP±Ca V 2.2/b 1b , (C) GFP±Ca V 2.2/b 1b /g 7 , (D) g 7 -myc/his, (E) K V 3.1b or (F) K V 3.1b/g 7 -myc/his. The panels in column 1 show staining with Oregon Green±phalloidin, GFP¯uorescence or FITC-labelled myc Ab as stated; the panels in column 2 show Texas red staining for the g 7 subunit or K V 3.1b subunit as stated; the panels in column 3 display the blue DAPI staining of the nucleus; and the panels in column 4 show the merged images. The scale bar in (A±C) represents 10 mm and in (D±F), 20 mm. g 7 abolishes Ca V 2.2 calcium channel expression speci®city of the g 7 antibody (Ab) was determined by western blotting where it was observed to label a major band at~35 kDa when g 7 was expressed in COS-7 cells (data not shown).
Effect of co-expression of the g 7 subunit on the Ca V 2.2 protein levels GFP±Ca V 2.2 or untagged Ca V 2.2 expressed in COS-7-cells are detectable by western blot using an Ab against the II±III loop of Ca V 2.2 (band at~240 kDa). When the g 7 subunit was co-expressed with either the GFP±Ca V 2.2 or untagged Ca V 2.2, the intensity of the Ca V 2.2 band was greatly reduced, but expression of the protein was not completely abolished ( Figure 7B ). No smaller molecular weight bands were observed that might represent degradation products of the GFP±Ca V 2.2 or untagged Ca V 2.2 or partially synthesized protein. Similar results were obtained both in the absence and presence of the auxiliary b 1b subunit, and also using the anti-GFP Ab (data not shown). Additionally, the co-expression of g 7 or g 7 -myc/his with Ca V 2.2/b 1b did not reduce the expression of the b 1b subunit ( Figure 7C ). These data extend the ®ndings from confocal imaging and electrophysiology experiments by revealing that the g 7 subunit suppresses the expression of GFP± Ca V 2.2 protein rather than interfering with the correct conformational folding or traf®cking of the GFP-labelled protein that could result in reduced¯uorescence or recorded current densities.
Discussion
We have described the identi®cation of two genes that encode putative VDCC subunits g 7 and g 5 , by their sequence and structural homology to the mouse stargazin gene (cacng2), and have cloned and expressed the cDNA for both human and mouse g 7 . The g 7 subunit is predicted to be a 275 amino acid, 31 kDa protein possessing four transmembrane-spanning domains with intracellular Nand C-termini. The in silico sequence for g 5 also predicts a 275 amino acid, 31 kDa protein with identical transmembrane topology to g 7 . Their overall size is much closer to that predicted for the skeletal muscle g 1 subunit than for the neuronal g 2 , g 3 and g 4 subunits. Their sequence homology with the g 1 subunit is extremely low, but both the g 7 and g 5 subunits possess~25% identity to the human g 2 subunit, with higher degrees of conservation occurring in the predicted transmembrane regions (up to 36%). It must also be noted that the C-termini of the g 7 and g 5 subunits differ from those of g 2 , g 3 and g 4 subunits, as they are much shorter and lack the classical consensus motif for interaction with PDZ domains (Kornau et al., 1997; Tomita et al., 2001 ). This C-terminal motif of g 2 (also present in g 3 and g 4 subunits) has been shown to play a crucial role in traf®cking AMPA (a-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate) receptor subunits to their correct location in the postsynaptic density (Chen et al., 2000) . This difference suggests that g 7 and g 5 may have a different function from that of the g 2 , g 3 and g 4 subunits.
The g 7 and g 5 subunits are, however, 70.5% identical to one another and, unlike all other putative g subunits, are assembled from ®ve exons, the ®rst four of which are identical to exons 1±4 of the genes encoding the previously predicted g 7 and g 5 subunits (Burgess et al., 1999 (Burgess et al., , 2001 . Sequence analysis of the BAC clones in which these genes were found suggests that the previously predicted four-exon g 7 and g 5 subunit sequences result from inclusion of intronic sequences at the exon 4±intron 4 boundary of CACNG7 and CACNG5 ( Figure 1B) . Inspection of the sequence of intron 4 of CACNG7 and CACNG5 reveals that in-frame stop codons are found 25 and 319 nucleotides, respectively, downstream of the exon 4±intron 4 boundary. The ®nal eight C-terminal amino acids of the predicted four-exon g 7 are encoded by the ®rst 24 bases of intron 4 before a stop codon. Similarly, the C-terminal 106 amino acids of the predicted four-exon g 5 would be encoded by the entirety of intron 4, resulting in a C-terminal g 5 sequence which has extremely low sequence homology to the other g subunits.
The sequence of the corresponding mouse orthologues of the predicted human four-exon g 7 and g 5 can be deduced by analysis of the relevant mouse BACs. However, the stop codons within the fourth intron of each mouse gene are not in the same or even similar positions to their human equivalents, and their C-terminal regions do not retain homology to their human counterparts. In contrast, the in silico prediction of the mouse ®ve-exon g 5 sequence exhibits 89.5% identity to that of human g 5 at the nucleic acid level and 97% identity at the protein level. Our results strongly indicate that the previously predicted four-exon g 5 and g 7 subunits are not expressed in vivo.
The g 5 and g 7 subunits represent a distinct subdivision of the g subunit family of proteins identi®ed by structural and sequence homology to stargazin. In addition to the lower sequence homology to the neuronal g 2 , g 3 and g 4 subunits, the identi®cation of these gene products, assembled from ®ve exons rather than four, as in the case for the stargazin gene and its closer homologues, is evidence for further evolutionary diversion from a common ancestor. This conclusion was also reached in a recent genomic analysis of the g subunit superfamily (Chu et al., 2001) .
Northern blot analysis of the g 7 mRNA revealed it to be expressed exclusively in neuronal tissue. Two probes were used in different hybridizations, one speci®c for fulllength g 7 and the other, used in RT±PCR-based expression analysis in the previous study (Burgess et al., 2001) , which would detect mRNAs for both full-length g 7 and the putative four-exon g 7 . Both probes hybridized to~2.4 and 3 kb mRNAs, with identical expression patterns in all tissues in which they are expressed. Thus the two bands cannot represent separate transcripts for the previously predicted four-exon g 7 and the ®ve-exon g 7 described here. It would appear highly unlikely, given these data, that the four-exon g 7 is expressed in vivo.
Co-expression of the g 7 subunit almost completely abolished Ba 2+ current through N-type Ca V 2.2 VDCCs expressed in both Xenopus oocyte and COS-7 mammalian expression systems. It also signi®cantly reduced maximum Ba 2+ conductance in the non-N type Ca V 2.1 and Ca V 1.2 VDCCs, but the effects were not so pronounced. In contrast to the effects of the neuronal g 2 subunit, which has been reported in a previous study to inhibit N-type Ca V 2.2/ b 3 /a2d 1 currents by~37% (Kang et al., 2001) , the in¯uence of the g 7 subunit is not dependent upon coexpression of an exogenous a2d subunit as part of the Ca 2+ channel complex.
Several mechanisms could underlie the suppression of VDCC currents by the g 7 subunit, including: (i) interference with the functioning of the channel at the plasma membrane; (ii) inhibition of the delivery of the channel to the plasma membrane; (iii) prevention of the correct folding of the pore-forming subunit; (iv) more rapid protein degradation; and (v) suppression of channel protein synthesis.
Confocal imaging of COS-7 cells transiently expressing N-terminally tagged GFP±Ca V 2.2 Ca 2+ channel complexes revealed that co-expression of the g 7 protein, which itself is highly expressed throughout the cell, resulted in an almost complete loss of GFP¯uorescence. This suggested reduced synthesis or stability of GFP±Ca V 2.2, or interference of the g 7 subunit with the correct folding of the GFPtagged protein. Western blot analysis of the levels of both GFP±Ca V 2.2 and untagged Ca V 2.2 revealed that coexpression of g 7 results in a much reduced steady-state level of Ca V 2.2. This is likely to be due to a reduction in the level of Ca V 2.2 protein synthesized when g 7 is coexpressed, because no smaller molecular weight products of degradation were evident. It nevertheless is also possible that g 7 induces rapid and complete targeting of Ca V 2.2 to a degradation pathway. Whilst northern blot analysis is required to examine whether the Ca V 2.2 mRNA level is reduced in the presence of g 7 , we have noted in the present study that the reduction in Ca V 2.2 protein level still occurs following the removal of its 3¢-untranslated region (UTR) (Figure 7B ), which has been implicated in message stability (Schorge et al., 1999) .
These results raised the possibility that the g 7 was causing a non-speci®c inhibition of transcription or translation. However, we have shown that the in¯uence of g 7 does not cause a generalized down-regulation of all heterologously expressed ion channels, because the I±V relationship for the voltage-dependent potassium channel K V 3.1b expressed in Xenopus oocytes was unaffected by co-expression of the g 7 subunit. Furthermore, immunocytochemistry experiments con®rmed that the expression of K V 3.1b in COS-7 cells was unaltered by the coexpression of the g 7 subunit and there was little effect on expression of the VDCC b 1b subunit.
Our results bear a striking resemblance to the dominantnegative synthesis suppression of the Ca V 2.2 subunit induced by the co-expression of truncated Ca V 2.2 constructs (Raghib et al., 2001) . In that investigation, it was proposed that the translation of full-length Ca V 2.2 was halted when domain I or domain I±II of Ca V 2.2 interacted with the initially synthesized transmembrane a-helices of the nascent full-length Ca V 2.2. We do not yet know if a similar mechanism might be invoked for the downregulation of Ca V 2.2 by g 7 .
Further evidence indicates that the in¯uence of g 7 expression may be upon newly synthesized Ca V 2.2 protein. Transient expression of the g 7 subunit in sympathetic neurones did not signi®cantly alter endogenous (largely N-type) calcium current densities. The g 7 subunit therefore does not affect the function of pre-existing functional N-type channels.
It appears that the in¯uence of g 7 on VDCC expression and function is via a mechanism unlike that reported previously for the other stargazin-like proteins. Nevertheless, in the present study, inhibition of expression by the g 7 subunit is apparently speci®c for VDCC subunits, particularly Ca V 2.2, because its co-expression with K V 3.1b did not inhibit the expression of the potassium channel.
That g 7 is actually a subunit of a functional plasma membrane calcium channel complex appears unlikely, at least for Ca V 2.2. This is reinforced by the absence of signi®cant endogenous g 7 in sympathetic neurones, where the current is predominantly N-type. Future work will examine in which cell types g 7 is expressed endogenously in the brain, and whether its endogenous function is to down-regulate Ca V 2.2 expression.
Materials and methods

Text-based in silico cloning
The GenBank and EMBL databases were searched for sequences possessing homology to the full-length sequence of the mouse stargazin gene (Letts et al., 1998) . ESTs and genomic sequences from both databases were clustered to identify overlapping identical sequence belonging to the same transcript using the GCG package (Wisconsin Package Version 9.0, Genetics Computer Group) and a program developed by GlaxoSmithKline Research and Development Bioinformatics group, termed ESTBlast (Gill et al., 1997) . Multiple sequence alignments of conceptually translated proteins were aligned using the Clustal_W algorithm (Omiga 1.1, Oxford Molecular Group, Oxford, UK).
Cloning of stargazin-like genes
An RT±PCR approach was used to amplify the complete ORFs or partial sequences of predicted g-subunits either from cDNA derived from RNA or from overlapping partial clones. Human brain total RNA (Invitrogen, Paisley, UK) or mouse cerebellar total RNA puri®ed from the cerebella of 31-day-old mice using the RNeasy kit (Qiagen, Crawley, UK) were used to generate cDNA using the Superscript Pre-ampli®cation System (Invitrogen) primed with random hexamers.
Cloning human g 7 . The g 7 , 487 bp fragment predicted by in silico cloning was ampli®ed from 25 ng of Superscript-synthesized human brain cDNA using 25 pmol each of primer pair 5¢-CGGGAGAAAGG-TCGCTGT-3¢ and 5¢-TCATTTGGATGGACACGTCG-3¢. This was then extended by 5¢ and 3¢ RACE protocols using Marathon Ready total human brain cDNA (BD Biosciences Clontech, Basingstoke, UK). The complete nucleotide sequence of g 7 was assembled from two of the generated RACE clones and the original 487 bp clone by a splice overlap PCR protocol using a primer pair speci®c for the predicted ORF. The cDNA was sequenced then subcloned into a modi®ed pMT2 expression vector (Swick et al., 1992) . Human g 7 -myc/his was constructed by amplifying the complete ORF minus the stop codon from the pMT2-g 7 clone and inserting the fragment in-frame into the multiple cloning site of pCDNA3.1 myc/his A (+) (Invitrogen) using the NotI and ApaI restriction sites.
Cloning mouse g 7 . The nucleotide sequence of the human g 7 was compared with the HTGS subset of GenBank using BLASTn and tBLASTn with default parameters. The complete coding sequence was found within chromosome 19 BAC AC079557 and used to design genespeci®c primers 5¢-ATGAGTCACTGCAGCAGCCG-3¢ and 5¢-TCA-GCACGGCGAAGTGGAGA-3¢. The complete ORF was ampli®ed in a single PCR from 20 ng of mouse cerebellar cDNA and cloned into pCR4-TOPO for sequencing, and subcloned into pMT2 and pRK5 for expression in Xenopus oocytes/COS-7 cells or SCG neurones, respectively.
Northern blots
Human 12-lane multiple tissue blots and brain II and IV blots (BD Biosciences Clontech) were hybridized at 65°C in ExpressHyb solution (BD Biosciences Clontech) according to the manufacturer's instructions. The a-32 P-radiolabelled g 7 probes corresponding to nucleotides 576±763 or 80±482 were assembled according to the Strip-EZ DNA Probe Synthesis Removal Kit [Ambion (Europe) Ltd, Huntingdon, UK]. The ®nal stringency wash performed was 0.1Q SSC, 0.1% SDS at 65°C.
Other cDNA clones
The following cDNAs were used: rabbit Ca V 2.2 (D14157), N-terminal GFP-tagged rabbit Ca V 2.2 (Raghib et al., 2001) , rabbit Ca V 2.2 D3¢UTR, rabbit Ca V 2.1 (X57689), rat brain Ca V 1.2 (isoform CII, M67515), rat b 1b (X61394, except R417S, V435, V449A, W492R, V511A, a gift from Dr T.P.Snutch), mouse a2d 2 (AF247139, common brain splice variant), mut3b GFP (M62653, except S72A and S65G, a gift from Dr T.E.Hughes) and rat K V 3.1b (M68880). The 3¢-UTR of rabbit Ca V 2.2 was removed to generate Ca V 2.2 D3¢UTR, by introducing an SpeI site immediately after the stop codon by PCR and subcloning the Ca V 2.2 back into the vector. All cDNAs were subcloned into expression vector pMT2 (Swick et al., 1992) , with the exception of K V 3.1b that was in pRC-CMV.
Cell culture and transfections
Monkey COS-7 cells were cultured as previously described (Brice et al., 1997) . Transfection was performed with Geneporter transfection reagent (Gene Therapy Systems, San Diego, CA). Cells were plated onto coverslips 2±3 h prior to transfection. The DNA and Geneporter reagent (2 mg and 10 ml, respectively) were each diluted in 500 ml of serum-free medium, mixed, and applied to the cells. The a 1 , b, a2d and g subunits were mixed and transfected in a 1:1:1:1 ratio by DNA weight. In the absence of a2d and/or g 7 subunit, blank pMT2 vector was substituted. After 3.5 h, 1 ml of medium containing 20% serum was added to the cells, which were then incubated at 37°C for 3 days. Prior to electrophysiological recording, cells were re-plated using a non-enzymatic cell dissociation solution (Sigma, Dorset, UK) and maintained at 27°C for between 2 and 6 h. Cells for immunocytochemistry were not re-plated.
Electrophysiology
Xenopus oocytes. Xenopus oocytes were prepared, injected and utilized for electrophysiology as previously described (Canti et al., 1999) , with the following exceptions. Plasmid cDNAs for the different VDCC subunits were mixed in a weight ratio of 1:1:1:1. The recording solution for Ca V 2.2-injected oocytes contained: 5 mM Ba(OH) 2 , 80 mM TEA-OH, 2 mM CsOH and 5 mM HEPES (pH 7.4 with methanesulfonic acid). The Ba(OH) 2 concentration was raised to 10 mM for recording Ca V 1.2 and Ca V 2.1 currents. K V 3.1b currents were recorded 3 days after intranuclear injection of oocytes with 9 nl of cDNA together with an equal amount of g 7 in pMT2, or water for the control. The external medium contained: 96 mM NaCl, 5 mM HEPES, 2 mM KCl, 1 mM MgCl 2 and 1.8 mM CaCl 2 (pH 7.4).
COS-7 cells. Recordings were made from¯uorescent COS-7 cells expressing GFP±Ca V 2.2. Because GFP±Ca V 2.2 was only weaklȳ uorescent, free GFP (ratio 0.1) was included in the transfection to identify transfected cells from which recordings were made. Whole-cell patch±clamp recording was performed as previously described (Meir et al., 2000) . Ba 2+ (1 mM) was used as a charge carrier, except in the presence of g 7 subunit where 10 mM Ba 2+ was also used. Experiments were performed at room temperature. Data are expressed as mean T SEM. Statistical analysis was performed using paired or unpaired Student's t-test, as appropriate.
SCG preparation, transfection and electrophysiology Sympathetic neurones were isolated from 17-day-old Sprague±Dawley rats killed by CO 2 inhalation, following a modi®ed procedure described by Delmas et al. (1998) , in which collagenase type IA (500 U/ml, Sigma) and trypsin type XI (3000 U/ml, Sigma) were used. Aliquots of the cell suspension were transferred immediately to the electroporation cuvettes together with 10 mg of each of the cDNAs to be transfected. After electroporation (Morales et al., 2000) (250 V, 900 mF, EasyjecT Plus, EquiBio, Ashford, UK), the cells were resuspended in pre-warmed growth medium, plated on poly-L-lysine (Sigma)-coated Petri dishes and incubated at 37°C, 5% CO 2 , for 36±48 h before use for immunocytochemistry or electrophysiological experiments. Currents were elicited in the whole-cell patch±clamp con®guration from a holding potential of ±80 mV by 100 ms steps from ±40 to +40 mV. Otherwise all other recording conditions were as described above, with the exception of the addition of 0.5 mM tetrodotoxin to the extracellular solution.
Antibody generation
The peptide identi®ed in Figure 1A was synthesized by standard solidphase techniques, puri®ed by gel ®ltration chromatography and used to generate polyclonal anti-g 7 rabbit Abs as previously described (Amaya et al., 2000) . His-tagged rat b 1b subunit, puri®ed essentially as previously described (Canti et al., 2001) , was used to generate the polyclonal rabbit b 1b Ab.
Immunocytochemistry COS-7 cells or SCG neurones were ®xed and permeabilized for immunocytochemistry essentially as previously described (Brice et al., 1997) . Primary Abs, af®nity-puri®ed anti-g 7, anti-myc (AutogenBioclear, Calne, UK) and anti-K V 3.1b (Alomone labs, Jerusalem, Israel) were used at 0.8, 4 and 1.5 mg/ml, respectively. Anti-b 1b antiserum was used at 1:1000 dilution. Secondary biotin-conjugated goat antimouse (Molecular Probes, Eugene, OR) or goat anti-rabbit (Sigma, Dorset, UK) Abs were applied at 10 and 5 mg/ml, respectively. Texas redor¯uorescein isothiocyanate (FITC)-conjugated streptavidin were applied at 3.33 mg/ml. In co-labelling experiments, K V 3.1b was labelled with goat anti-rabbit Texas red-conjugated secondary Ab at 10 mg/ml (Molecular Probes). In some experiments, cells were incubated for 20 min with Oregon Green±phalloidin (6.6 mM, Molecular Probes). The nuclear dye 4¢,6-diamidino-2-phenylindole (DAPI; 300 nM, Molecular Probes) was also used to visualize the nucleus. Cells were examined on a confocal scanning laser microscope (Leica TCS SP, Milton Keynes, UK). All images were scanned sequentially to eliminate cross-talk, and photomultiplier settings were kept constant in each experiment.
Western blotting COS-7 cells were processed as previously described (Raghib et al., 2001) . Samples (50 mg of total protein/lane in Figure 7B and 10 mg of total protein/lane in Figure 7C ) were separated by SDS±PAGE using 4±20% gradient gels and then transferred electrophoretically to polyvinylidenē uoride membranes. The membranes were blocked with 3% bovine serum albumin (BSA) for 5 h at 55°C and then incubated overnight at 20°C with either 1.2 mg/ml of an anti-peptide Ab raised in rabbits against residues 846±861 within the II±III loop of rabbit brain Ca V 2.2 (Raghib et al., 2001) , or a 1:1000 dilution of anti-rat b 1b antiserum. Secondary Ab (a 1:1000 dilution of goat anti-rabbit IgG±horseradish peroxidase conjugate) was added and the membranes incubated for 1 h. Following extensive washing, bound Abs were detected using enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech, Little Chalfont, UK).
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